REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/17/2025
Back to search
Official data from USPTO
CYREENE PHARMACY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CYREENE PHARMACY
ST13
US500000088633836Class
35
Filing
88633836
Registration
6201843
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
11/18/2025
Trademark type
Word
Nice classes
35
Filing date
09/27/2019
Registration date
11/17/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/17/2020
Last transaction
11/18/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/01/2019
First use in commerce
05/01/2020
Drawing code
4
Owner type
16
Owner location
CALIFORNIA, MD
Examiner
MAHONEY,PAULA M
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Cyreene, LLC.
Representatives
Cyreene, LLC.
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Retail pharmacy services
Publications
History of USPTO decisions and trademark events.
34 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/17/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/13/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/10/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/07/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/07/2020
IUAF
USE AMENDMENT FILED
09/22/2020
EISU
TEAS STATEMENT OF USE RECEIVED
09/22/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/08/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/14/2020
PUBO
PUBLISHED FOR OPPOSITION
07/14/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/24/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/05/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/05/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/03/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/22/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/22/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/22/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/22/2020
CEPE
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
02/11/2020
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
02/11/2020
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
02/11/2020
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
02/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/16/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/16/2020
ALIE
ASSIGNED TO LIE
01/16/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/31/2019
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
12/31/2019
GPRA
PRIORITY ACTION E-MAILED
12/31/2019
CPRA
PRIORITY ACTION WRITTEN
12/31/2019
DOCK
ASSIGNED TO EXAMINER
12/31/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/02/2019
NWAP
NEW APPLICATION ENTERED
10/01/2019
Continuous trademark protection
Get notified about every new filing that threatens CYREENE PHARMACY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.